Supernus Pharmaceuticals (SUPN) Current Leases (2020)
Supernus Pharmaceuticals (SUPN) posted quarterly Current Leases of $3.7 million for Q3 2020, up 32.42% on a QoQ basis from $2.8 million in Q4 2019.
Supernus Pharmaceuticals (SUPN) Current Leases (2020) Analysis & Trends
Supernus Pharmaceuticals has reported Current Leases for 2 years, with the latest figure at $3.7 million in Q3 2020.
- Current Leases for Q3 2020 came in at $3.7 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2020 was $3.7 million (changed N/A YoY), and the FY2019 annual result was $2.8 million, changed N/A from the prior year.
- Current Leases climbed to $3.7 million in Q3 2020, from $2.8 million in the prior quarter.
- Over five years, Current Leases peaked at $3.7 million in Q3 2020 and troughed at $2.8 million in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Supernus Pharmaceuticals | 2.74 Bn | 2.37 Bn | 185.39 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 3.74 Mn |